后疫情时代疫苗接种咨询中的问题:对假设疫苗与新型疫苗开放式应答的两项质性分析
两项质性分析考察德国民众在接种假设疫苗(研究1,n=842)和新型呼吸道合胞病毒(RSV)疫苗(研究2,n=1127,60岁以上)时向医生提出的问题。参与者常关注疫苗安全性、副作用和禁忌证(尤其合并基础疾病时),也关注效力、加强针时机、免疫程序、疫苗类型和疾病发病率,并重视医生信任与官方指南。
要点
- 接种咨询常聚焦安全性、副作用和禁忌证,合并基础疾病者尤为关注。
- 效力、加强针时机、免疫程序、疫苗类型和疾病发病率也是常见问题。
- 参与者重视对医生的信任,希望明确医学建议与官方指南。
核心结论
- 医疗服务提供者应调整沟通策略,聚焦共同决策和个性化疫苗接种决策,涵盖新型与已知的接种决策决定因素。
研究设计与样本
- 研究1纳入842名德国参与者,提供虚构疾病(dysomeria)及疫苗信息后询问咨询问题。
- 研究2纳入1127名60岁以上人群,提供新型RSV疫苗信息后询问同一开放式问题。
- 两项研究均为质性分析,采用研究1归纳建立的分分类系统对两项研究回答进行编码。
主要发现
- 参与者常提出疫苗安全性、副作用和禁忌证担忧,尤其涉及合并基础疾病时。
- 问题还聚焦效力、加强针时机、免疫程序、疫苗类型和疾病发病率。
- 对医生的信任很重要,参与者寻求医学推荐和官方指南的明确信息。
临床怎么用
- 医疗服务提供者应调整沟通策略,聚焦共同决策和个性化疫苗接种决策,涵盖新型与已知的接种决策决定因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We examine patients' informational needs regarding novel vaccination decisions, focusing on what information they expect to receive in doctor-patient communication after having lived through a pandemic. METHOD: In Study 1, n = 842 German participants received information on a fictional disease and vaccination (called dysomeria), including symptoms, disease impact, vaccine efficacy, and potential side effects. They were asked what questions they would ask their doctor in a consultation. In Study 2, we included n = 1127 people over the age of 60. The participants received information about the novel Respiratory Syncytial Virus (RSV) vaccine and then, they were asked the same open-ended question as in Study 1. RESULTS: An inductively developed categorization system from Study 1 proved effective for coding responses in both studies. Participants frequently raised concerns about vaccine safety, side effects, and contraindications-especially in the context of preexisting medical conditions. Questions also focused on efficacy, booster timing, immunization schedules, vaccine types, and disease incidence. Trust in physicians was important, with participants seeking clarity on both medical recommendations and official guidelines. CONCLUSIONS: Healthcare providers should adapt communication strategies, focusing on shared decision-making and personalized vaccination decisions including novel and well-known determinants of vaccination decisions.
引用
- Shamsrizi P, Eitze S, Heinemeier D, et al. Post-pandemic questions in vaccination counseling: Two qualitative analyses of open-ended responses comparing hypothetical and novel vaccines. Vaccine. 2025. PMID: 41066985. doi:10.1016/j.vaccine.2025.127823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。